Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CIEN vs GSK✓SelectedUSD · GSKCIEN vs GSK performance historyLatest closeAs of-10.76%11/20
Stock and ETF performance explorer

CIEN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+32.8%
GSK return
+6.1%
Excess return
+26.7%
Maximum drawdown
-63.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-10.8%-0.1%-10.6%-10.8%
7D-16.5%-5.3%-11.1%-17.6%
30D-35.1%-3.7%-31.5%-35.4%
3M-40.3%-7.3%-33.0%-39.8%
6M-57.8%-4.2%-53.5%-57.7%
YTD+0.2%+0.9%-0.7%-1.7%
1Y+32.8%+7.3%+25.5%+27.4%
All+32.8%+6.1%+26.7%+27.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling